Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial F
| Image |  |
|---|---|
| Description | article by Sameer Bansilal et al published October 2015 in American Heart Journal |
| Author/s |
author: Kenneth W Mahaffey Graeme J. Hankey Manesh Patel Keith Fox Zachary T Bloomgarden Werner Hacke Scott D Berkowitz Yuliya Lokhnygina Günter Breithardt Daniel E. Singer Jonathan L. Halperin Jonathan P. Piccini Christopher C Nessel Sameer Bansilal Richard C Becker Anne S Hellkamp |
| Publication date | October 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |